Evidence map›Paper›PMID 41699942›Full record

ArticleJournal of biomedical materials research. Part A2026

In Vitro Evaluation of Escherichia coli and Staphylococcus aureus Translocation in 3D Printed Material.

Ashma Sharma, Joshua Prince, A-Andrew D Jones

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

  • Update of
    2026
5 · Who and what money

Authors and funding

3 authors.

Ashma SharmaDepartment of Civil & Environmental Engineering, Pratt School of Engineering, Duke University, Durham, North Carolina, USA.ORCID 0000-0002-4482-9449
Joshua PrinceDepartment of Civil & Environmental Engineering, Pratt School of Engineering, Duke University, Durham, North Carolina, USA.ORCID 0000-0001-6050-9544
A-Andrew D JonesDepartment of Civil & Environmental Engineering, Pratt School of Engineering, Duke University, Durham, North Carolina, USA.ORCID 0000-0003-3840-8039

Funding

Developing platforms for studying the impact of external stresses on multispecies biofilms.R35GM142898 · NIGMS · DUKE UNIVERSITY · PI JONES, AKHENATON-ANDREW DHAFIR · 2021 to 2025
$2.1M
NIGMS NIH HHS NIH R35 GM142898NIGMS NIH HHS R35 GM142898
6 · The paper itself

Abstract

Vascular graft infection is a rare but life-threatening condition, primarily occurring after 30 days post-surgery. Meta-analysis has shown that antimicrobial coatings on graft materials do not prevent these infections. Moreover, infections still occurs even though studies have shown that there is no bacterial proliferation or bacterial penetration of common vascular graft material. The time frame of infection, meta-analysis, and in situ studies suggest that bacteria present at the suture site are introduced into the surrounding tissue or that systemically circulating bacteria may be surviving, proliferating, diffusing slowly, and evading host immune defense in synthetic vascular grafts. De novo vascular graft materials, such as tissue-engineered vascular graft material and decellularized vasculature may provide an in situ platform for studying survival, proliferation, and diffusion in tissue and tissue-like materials. In this study, we used confocal microscopy to image the penetration depth of bacteria over time as a proxy for the diffusion of Staphylococcus aureus and Escherichia coli into alginate, GelMA, and decellularized porcine vascular tissue. We quantified viable bacteria breakthrough as a function of biomaterial type. We found that the penetration depth over time was similar in all three biomaterials, however E. coli broke through much less from tissue than from engineered materials, while S. aureus had higher breakthrough in the GelMa but otherwise equal rates. These results point to the possibility of interstitial growth control relative to surface coatings as a future target for engineering infection resistance in engineered vascular grafts.

Indexed as

Biocompatible MaterialsBlood Vessel ProsthesisEscherichia coliPrinting, Three-DimensionalStaphylococcus aureusAlginatesAnimalsSwineAlginatesBiocompatible Materials

Identifiers

PMID41699942
PMCPMC13034611

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.